Skip to main content
Erschienen in: Annals of Surgical Oncology 11/2009

01.11.2009 | Breast Oncology

Magnetic Resonance Imaging in the Planning of Initial Lumpectomy for Invasive Breast Carcinoma: Its Effect on Ipsilateral Breast Tumor Recurrence After Breast-Conservation Therapy

verfasst von: Nicholas Hwang, BSc, Dan E. Schiller, MD, MSc, FRCSC, Pavel Crystal, MD, Ellen Maki, PhD, David R. McCready, MD, MSc, FRCSC

Erschienen in: Annals of Surgical Oncology | Ausgabe 11/2009

Einloggen, um Zugang zu erhalten

Abstract

Background

It remains uncertain whether routine preoperative breast magnetic resonance imaging (MRI) will lead to improved local outcomes after breast-conserving surgery (BCS) and radiation (RT) for invasive carcinoma. The purpose of this study was to determine whether MRI in the planning of the first lumpectomy reduces ipsilateral breast tumor recurrence (IBTR).

Methods

Using a prospective database, 472 initial lumpectomies from 463 women between 1999 and 2005 were examined. All patients had invasive cancer excised to negative margins on BCS, received RT, and were followed. IBTR rates were calculated by Kaplan–Meier method. Univariate and multivariate analyses were performed to investigate the association between MRI for initial lumpectomies and IBTR outcomes.

Results

MRI was performed before 127 (27%) lumpectomies, while 345 (73%) patients did not have a preoperative breast MRI. At median follow-up of 54 months (range 4.8–111.6 months), there was no significant difference in actuarial 8-year IBTR rates between women with preoperative MRI evaluation and women without MRI (1.8% versus 2.5%, respectively; P = 0.67). After adjusting for adjuvant therapies, patient, and tumor characteristics, there continued to be no increased risk of IBTR [hazard ratio (HR) 1.7; P = 0.60]. MRI visualization of tumors prior to lumpectomy did not influence the achievement of negative margins and was not associated with lower rates of re-excision (MRI: 11.8% versus no-MRI: 13.3%; P = 0.50).

Conclusion

MRI evaluation of invasive carcinoma in the planning of initial lumpectomies was not associated with improved local outcomes after BCS with RT in this cohort of patients.
Literatur
1.
Zurück zum Zitat Keclz F, Santyr G. Gadolinium-enhanced breast MRI. Crit Rev Diagn Imaging. 1995;36:287–338. Keclz F, Santyr G. Gadolinium-enhanced breast MRI. Crit Rev Diagn Imaging. 1995;36:287–338.
2.
Zurück zum Zitat Orel S. High resolution MR imaging for the detection, diagnosis and staging of breast cancer. RadioGraphics. 1998;18:903–12.PubMed Orel S. High resolution MR imaging for the detection, diagnosis and staging of breast cancer. RadioGraphics. 1998;18:903–12.PubMed
3.
Zurück zum Zitat Boetes C, Strijik SP, Holland R, et al. False-negative MR imaging of malignant breast tumors. Eur Radiol. 1997;7:1231–4.CrossRefPubMed Boetes C, Strijik SP, Holland R, et al. False-negative MR imaging of malignant breast tumors. Eur Radiol. 1997;7:1231–4.CrossRefPubMed
4.
Zurück zum Zitat Teifke A, Hlawatsch A, Beier T, et al. Undetected malignancies of the breast: Dynamic contrast-enhanced MR imaging at 1.0T. Radiology. 2002;224:881–8.CrossRefPubMed Teifke A, Hlawatsch A, Beier T, et al. Undetected malignancies of the breast: Dynamic contrast-enhanced MR imaging at 1.0T. Radiology. 2002;224:881–8.CrossRefPubMed
5.
Zurück zum Zitat Orel S. Who should have breast magnetic resonance imaging evaluation? J Clin Oncol. 2008;26:703–11.CrossRefPubMed Orel S. Who should have breast magnetic resonance imaging evaluation? J Clin Oncol. 2008;26:703–11.CrossRefPubMed
6.
Zurück zum Zitat Van Goethem M, Tjalma W, Schelfout L, et al. Magnetic resonance imaging in breast cancer. EJSO. 2006;32:901–10.CrossRefPubMed Van Goethem M, Tjalma W, Schelfout L, et al. Magnetic resonance imaging in breast cancer. EJSO. 2006;32:901–10.CrossRefPubMed
7.
Zurück zum Zitat Morrow M, Freedman G. A clinical oncology perspective on the use of breast MR. Magn Reson Imaging Clin North Am. 2006;14:363–78.CrossRef Morrow M, Freedman G. A clinical oncology perspective on the use of breast MR. Magn Reson Imaging Clin North Am. 2006;14:363–78.CrossRef
8.
Zurück zum Zitat Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Eng J Med. 2002;347:1233–41. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Eng J Med. 2002;347:1233–41.
9.
Zurück zum Zitat Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet. 2005;366:2087–106.PubMed Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet. 2005;366:2087–106.PubMed
10.
Zurück zum Zitat Fischer U, Zachariae, Baum F, et al. The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol. 2004;14:1725–31.PubMed Fischer U, Zachariae, Baum F, et al. The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol. 2004;14:1725–31.PubMed
11.
Zurück zum Zitat Solin LJ, Orel SG, Hwang WT, et al. Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. J Clin Oncol. 2008;26:386–91.CrossRefPubMed Solin LJ, Orel SG, Hwang WT, et al. Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. J Clin Oncol. 2008;26:386–91.CrossRefPubMed
12.
Zurück zum Zitat Orel SG, Schnall MD.MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology. 2001;220:13–30.PubMed Orel SG, Schnall MD.MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology. 2001;220:13–30.PubMed
13.
Zurück zum Zitat Whelan T, MacKenzie R, et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst. 2002;94(15):1143–50.PubMed Whelan T, MacKenzie R, et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst. 2002;94(15):1143–50.PubMed
14.
Zurück zum Zitat The Breast Cancer Disease Site Group. Adjuvant systemic therapy for node-negative breast cancer. Breast cancer evidence-based series and practice guidelines. Cancer Care Ontario. 1–8 PG; May 2003. The Breast Cancer Disease Site Group. Adjuvant systemic therapy for node-negative breast cancer. Breast cancer evidence-based series and practice guidelines. Cancer Care Ontario. 1–8 PG; May 2003.
15.
Zurück zum Zitat The Breast Cancer Disease Site Group. The role of aromatase inhibitors in adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer. Breast cancer evidence-based series and practice guidelines. Cancer Care Ontario. 1–18 EBS; February 2008. The Breast Cancer Disease Site Group. The role of aromatase inhibitors in adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer. Breast cancer evidence-based series and practice guidelines. Cancer Care Ontario. 1–18 EBS; February 2008.
16.
Zurück zum Zitat Houssami N, Ciatto S, Macaskill P, Lord SJ, Warren RM, Dixon JM, et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol. 2008;26(19):3248–58. Epub 2008 May 12.CrossRefPubMed Houssami N, Ciatto S, Macaskill P, Lord SJ, Warren RM, Dixon JM, et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol. 2008;26(19):3248–58. Epub 2008 May 12.CrossRefPubMed
17.
Zurück zum Zitat Morrow M, Harris JR. Local management of invasive breast cancer. In: Harris JR, Lippman ME, Morrow M, Osborne CK, editors. Diseases of the breast. 2nd ed. Philadelphia: Lippincott, Williams & Wilkins; 2000. p. 515–60. Morrow M, Harris JR. Local management of invasive breast cancer. In: Harris JR, Lippman ME, Morrow M, Osborne CK, editors. Diseases of the breast. 2nd ed. Philadelphia: Lippincott, Williams & Wilkins; 2000. p. 515–60.
18.
Zurück zum Zitat Morrow M. Magnetic resonance imaging in the breast cancer patient: curb your enthusiasm. J Clin Oncol. 2008;26(3):352–3.CrossRefPubMed Morrow M. Magnetic resonance imaging in the breast cancer patient: curb your enthusiasm. J Clin Oncol. 2008;26(3):352–3.CrossRefPubMed
19.
Zurück zum Zitat Wallace AM, Daniel BL, Jeffrey SS, et al. Rates of reexcision for breast cancer after magnetic resonance imaging-guided bracket wire localization. J Am Coll Surg. 2005;200:527–37.CrossRefPubMed Wallace AM, Daniel BL, Jeffrey SS, et al. Rates of reexcision for breast cancer after magnetic resonance imaging-guided bracket wire localization. J Am Coll Surg. 2005;200:527–37.CrossRefPubMed
20.
Zurück zum Zitat Lehman CD, Gatsonia C, Kuhl CK, et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Eng J Med 2007;356:1295–303.CrossRef Lehman CD, Gatsonia C, Kuhl CK, et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Eng J Med 2007;356:1295–303.CrossRef
21.
Zurück zum Zitat Sardanelli F, Giuseppetti GM, Panizza P, Bazzocchi M, Fausto A, Simonetti G, et al. Italian trial for breast MR in multifocal/multicentric cancer. Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in Fatty and dense breasts using the whole-breast pathologic examination as a gold standard. AJR Am J Roentgenol. 2004;183(4):1149–57.PubMed Sardanelli F, Giuseppetti GM, Panizza P, Bazzocchi M, Fausto A, Simonetti G, et al. Italian trial for breast MR in multifocal/multicentric cancer. Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in Fatty and dense breasts using the whole-breast pathologic examination as a gold standard. AJR Am J Roentgenol. 2004;183(4):1149–57.PubMed
22.
Zurück zum Zitat Hollingsworth AB, Stough RG, O’Dell CA, Brekke CE. Breast magnetic resonance imaging for preoperative locoregional staging. Am J Surg. 2008;196(3):389–97.CrossRefPubMed Hollingsworth AB, Stough RG, O’Dell CA, Brekke CE. Breast magnetic resonance imaging for preoperative locoregional staging. Am J Surg. 2008;196(3):389–97.CrossRefPubMed
23.
Zurück zum Zitat Hlawatsch A, Teifke A, Schmidt M, Thelen M. Preoperative assessment of breast cancer: sonography versus MR imaging. AJR Am J Roentgenol. 2002;179(6):1493–501.PubMed Hlawatsch A, Teifke A, Schmidt M, Thelen M. Preoperative assessment of breast cancer: sonography versus MR imaging. AJR Am J Roentgenol. 2002;179(6):1493–501.PubMed
24.
Zurück zum Zitat Berg WA, Gutierrez L, NessAiver MS, Carter WB, Bhargavan M, Lewis RS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology. 2004;233(3):830–49. Epub 2004 Oct 14.CrossRefPubMed Berg WA, Gutierrez L, NessAiver MS, Carter WB, Bhargavan M, Lewis RS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology. 2004;233(3):830–49. Epub 2004 Oct 14.CrossRefPubMed
25.
Zurück zum Zitat Schiller DE, Le LW, Cho B, et al. Factors associated with negative margins of lumpectomy specimen: potential use in selecting patients for intraoperative radiotherapy. Ann Surg Oncol. 2008;15(3):833–42.CrossRefPubMed Schiller DE, Le LW, Cho B, et al. Factors associated with negative margins of lumpectomy specimen: potential use in selecting patients for intraoperative radiotherapy. Ann Surg Oncol. 2008;15(3):833–42.CrossRefPubMed
26.
Zurück zum Zitat Wilkinson LS, Given-Wilson R, Hall T, Potts H, Sharma AK, Smith E. Increasing the diagnosis of multifocal primary breast cancer by the use of bilateral whole-breast ultrasound. Clin Radiol. 2005;60(5):573–8.CrossRefPubMed Wilkinson LS, Given-Wilson R, Hall T, Potts H, Sharma AK, Smith E. Increasing the diagnosis of multifocal primary breast cancer by the use of bilateral whole-breast ultrasound. Clin Radiol. 2005;60(5):573–8.CrossRefPubMed
27.
Zurück zum Zitat Moon WK, Noh DY, Im JG. Multifocal, multicentric, and contralateral breast cancers: bilateral whole-breast US in the preoperative evaluation of patients. Radiology. 2002;224(2):569–76.CrossRefPubMed Moon WK, Noh DY, Im JG. Multifocal, multicentric, and contralateral breast cancers: bilateral whole-breast US in the preoperative evaluation of patients. Radiology. 2002;224(2):569–76.CrossRefPubMed
28.
Zurück zum Zitat Berg WA, Gilbreath PL. Multicentric and multifocal cancer: whole-breast US in preoperative evaluation. Radiology. 2000;214(1):59–66.PubMed Berg WA, Gilbreath PL. Multicentric and multifocal cancer: whole-breast US in preoperative evaluation. Radiology. 2000;214(1):59–66.PubMed
29.
Zurück zum Zitat Di Saverio S, Catena F, Santini D, Ansaloni L, Fogacci T, Mignani S, et al. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up. Breast Cancer Res Treat. 2008;109(3):405–16.CrossRefPubMed Di Saverio S, Catena F, Santini D, Ansaloni L, Fogacci T, Mignani S, et al. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up. Breast Cancer Res Treat. 2008;109(3):405–16.CrossRefPubMed
30.
Zurück zum Zitat Silverstein MJ. An argument against routine use of radiotherapy for ductal carcinoma in situ. Oncology (Williston Park). 2003;17(11):1511–33 Silverstein MJ. An argument against routine use of radiotherapy for ductal carcinoma in situ. Oncology (Williston Park). 2003;17(11):1511–33
31.
Zurück zum Zitat Schnall MD, Blume J, Bluemke DA, et al. MRI detection of distinct incidental cancer in women with primary breast cancer studied in IBMC 6883. J Surg Oncol. 2005;92:32–8.CrossRefPubMed Schnall MD, Blume J, Bluemke DA, et al. MRI detection of distinct incidental cancer in women with primary breast cancer studied in IBMC 6883. J Surg Oncol. 2005;92:32–8.CrossRefPubMed
32.
Zurück zum Zitat Deurloo EE, Peterse JL, Rutgers EJ, et al. Additional breast lesions in patients eligible for breast-conserving therapy by MRI: impact on preoperative management and potential benefit of computerised analysis. Eur J Cancer. 2005;41:1393–401.CrossRefPubMed Deurloo EE, Peterse JL, Rutgers EJ, et al. Additional breast lesions in patients eligible for breast-conserving therapy by MRI: impact on preoperative management and potential benefit of computerised analysis. Eur J Cancer. 2005;41:1393–401.CrossRefPubMed
33.
Zurück zum Zitat Schelfout K, Van Goethem M, Kersschot E et al. Contrast-enhanced MR imaging of breast lesions and effect on treatment. Eur J Surg Oncol. 2004;30:501–7.CrossRefPubMed Schelfout K, Van Goethem M, Kersschot E et al. Contrast-enhanced MR imaging of breast lesions and effect on treatment. Eur J Surg Oncol. 2004;30:501–7.CrossRefPubMed
34.
Zurück zum Zitat Fisher B, Brown A, Mamounas E, et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol. 1997;15:2483–93.PubMed Fisher B, Brown A, Mamounas E, et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol. 1997;15:2483–93.PubMed
35.
Zurück zum Zitat Partridge SC, Gibbs JE, Lu Y, et al. MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival. AJR Am J Roentgenol. 2005;184:1774–81.PubMed Partridge SC, Gibbs JE, Lu Y, et al. MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival. AJR Am J Roentgenol. 2005;184:1774–81.PubMed
36.
Zurück zum Zitat Sardanelli F, Giuseppetti GM, Panizza P, et al. Sensitivity of MRI versus mammography for detecting multifocal, multicentric breast cancer in fatty and dense breasts using the whole-breast pathologic examination as a gold standard. AJR Am J Roentgenol. 2004;183:1149 –57.PubMed Sardanelli F, Giuseppetti GM, Panizza P, et al. Sensitivity of MRI versus mammography for detecting multifocal, multicentric breast cancer in fatty and dense breasts using the whole-breast pathologic examination as a gold standard. AJR Am J Roentgenol. 2004;183:1149 –57.PubMed
37.
Zurück zum Zitat Schelfout K, Van Goethem M, Kersshot E, et al. Preoperative breast MRI in patients with invasive lobular breast cancer. Eur Radiol. 2004;14:1209–16.CrossRefPubMed Schelfout K, Van Goethem M, Kersshot E, et al. Preoperative breast MRI in patients with invasive lobular breast cancer. Eur Radiol. 2004;14:1209–16.CrossRefPubMed
Metadaten
Titel
Magnetic Resonance Imaging in the Planning of Initial Lumpectomy for Invasive Breast Carcinoma: Its Effect on Ipsilateral Breast Tumor Recurrence After Breast-Conservation Therapy
verfasst von
Nicholas Hwang, BSc
Dan E. Schiller, MD, MSc, FRCSC
Pavel Crystal, MD
Ellen Maki, PhD
David R. McCready, MD, MSc, FRCSC
Publikationsdatum
01.11.2009
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 11/2009
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-009-0607-1

Weitere Artikel der Ausgabe 11/2009

Annals of Surgical Oncology 11/2009 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.